596 research outputs found
Magnetic resonance imaging for the treatment planning in invasive carcinoma of the cervix in pregnant women
Wearable device to assist independent living.
Older people increasingly want to remain living independently in their own homes. The aim of the ENABLE project is to develop a wearable device that can be used both within and outside of the home to support older people in their daily lives and which can monitor their health status, detect potential problems, provide activity reminders and offer communication and alarm services. In order to determine the specifications and functionality required for development of the device user surveys and focus groups were undertaken and use case analysis and scenario modeling carried out. The project has resulted in the development of a wrist worn device and mobile phone combination that can support and assist older and vulnerable wearers with a range of activities and services both inside and outside of their homes. The device is currently undergoing pilot trials in five European countries. The aim of this paper is to describe the ENABLE device, its features and services, and the infrastructure within which it operates
Perioperative, interstitial brachytherapy HDR - new prospects in the treatment of recurrent carcinoma of the cervix and endometrium
Prognostic value of the time interval between surgery and adjuvant radiotherapy in patients treated for early stage invasive cervical cancer
Sentinel lymph node in vulvar cancer - a pilot study to identify and assess the diagnostic value
EMon : embodied monitorization
Serie : Lecture Notes in Computer Science, vol. 5859The amount of seniors in need of constant care is rapidly rising: an
evident consequence of population ageing. There are already some
monitorization environments which aim to monitor these persons while they
remain at home. This, however, although better than delocalizing the elder to
some kind of institution, may not still be the ideal solution, as it forces them to
stay inside the home more than they wished, as going out means lack of
accompaniment and a consequent sensation of fear. In this paper we propose
EMon: a monitorization device small enough to be worn by its users, although
powerful enough to provide the higher level monitorization systems with vital
information about the user and the environment around him. We hope to allow
the representation of an intelligent environment to move with its users, instead
of being static, mandatorily associated to a single physical location. The first
prototype of EMon, as presented in this paper, provides environmental data as
well as GPS coordinates and pictures that are useful to describe the context of
its user
Effects of 60 MeV protons and 250 kV X-rays on cell viability
Particle radiotherapy such as the one using proton beams, provides a successful treatment approach in many cancer types. However, the cellular and molecular mechanisms by which proton irradiation induces cell death, particularly in a human peripheral blood lymphocyte model has not been examined in detail. Comparative studies of the biological effects, such as cell death, of particle therapy versus conventional X-rays treatment are of utmost importance. Here, we compared the viability of human peripheral blood lymphocyte following in vitro irradiation with protons (therapeutic 60 MeV proton beam) and photon beam (250 kV, X-rays), by applying separate doses within the range of 0.3-4.0 Gy. Cell viability was assessed 1 and 4 h after irradiation with protons and X-rays by the FITC-Annexin V labelling procedure (Apoptotic & Necrotic & Healthy Cells Quantification Kit, Biotium). Results showed that irradiation with both radiation types reduced the number of viable cells in a dose-dependent manner, as assessed as a function of the duration of post-irradiation time. Protons proved more fatal to the cells treated than X-ray photons. This demonstrates a difference in cell viability after irradiation with protons and photons in a human peripheral blood lymphocyte model
The first experimental campaign results of plasmas heated by a new 1 MW neutral beam injector on the COMPASS tokamak
- âŠ